CERRITOS, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ:STLN) ("STLN" or the "Company"), one of the largest value-based community oncology groups in the United States, today
CERRITOS, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. ("STLN") (NASDAQ:STLN) a pioneer in value-based community oncology care, today announced that the company will release its third
CERRITOS, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™, Inc. (NASDAQ:STLN), ("STLN" or the "Company"), one of the largest value-based community oncology groups in the United States,
CERRITOS, Calif., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™, Inc. (NASDAQ:STLN), ("STLN" or the "Company"), one of the largest value-based community oncology groups in the United States,
CERRITOS, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Starling Oncology™ Inc. (NASDAQ:STLN), ("STLN" or the "Company"), one of the largest value-based community oncology groups in the United States,
CERRITOS, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Starling Oncology, Inc. (NASDAQ:STLN) ("STLN" or the "Company"), one of the largest value-based community oncology groups in the United States, today
CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that it
